Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...

This week the University of Liverpool launched the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), an ...

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is ...

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

Discover how the global rare biomarkers market is expanding at 14.4% annually, fueled by non-invasive testing.

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8513 ...

The global HIV diagnostics market, valued at US$2.96B in 2024, is forecasted to grow at a 10.3% CAGR, reaching US$3.25B by ...

US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...

Damaged muscles in ALS patients release proteins previously linked only to brain disease In a nutshell Researchers discovered ...

Now Roche’s diagnostics division ... In the critical care setting, data from a patient’s hospital monitoring equipment will be integrated with their biomarker, genomic and sequencing data ...

The global tumor profiling market share analysis is on a strong growth trajectory, projected to reach USD 11.9 billion by 2025, with a CAGR of 8.3% from 2025 to 2035. This surge is fueled by the ...